The rising interest in GLP-1 agonists for diabetes has led to a debate about formats: patches versus tablets . Usually , GLP-1 therapies were exclusively available in oral form, but the introduction of https://jayaujmo280808.blog-a-story.com/22727930/glp-1-patches-vs-oral-medications-what-suitable-for-individuals